Author Correction: Circulating Levels of Inflammatory Proteins and Survival in Patients with Gallbladder Cancer (Scientific Reports, (2018), 8, 1, (5671), 10.1038/s41598-018-23848-8)
Abstract
This Article contains errors in the Results section. âThe median stage-adjusted survival time was 7.9 months longer in patients with the highest levels of TRAIL compared to those with the lowest levels (Table 2).â should read: âThe median stage-adjusted survival time was 7.1 months longer in patients with the highest levels of TRAIL compared to those with the lowest levels (Table 2).â In addition, this Article contains errors in Table 1, where the reported numbers of patients under the âRegular Aspirin useâ subheading are incorrect. The correct totals for âNoâ are 32 (100.0) and 97 (96.0) under Early-stage and Late-Stage respectively, and for âYesâ the correct totals are 0 (0.0) and 4(4.0) respectively.
Más información
| Título según SCOPUS: | Author Correction: Circulating Levels of Inflammatory Proteins and Survival in Patients with Gallbladder Cancer (Scientific Reports, (2018), 8, 1, (5671), 10.1038/s41598-018-23848-8) |
| Título de la Revista: | Scientific Reports |
| Volumen: | 10 |
| Número: | 1 |
| Editorial: | Nature Research |
| Fecha de publicación: | 2020 |
| Idioma: | English |
| DOI: |
10.1038/s41598-020-59761-2 |
| Notas: | SCOPUS |